Literature DB >> 9457823

Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: prognostic factors in 196 tumors.

H K Lee1, A G Antell, C A Perez, W L Straube, G Ramachandran, R J Myerson, B Emami, E P Molmenti, A Buckner, M A Lockett.   

Abstract

PURPOSE: To correlate patient-, tumor-, and treatment-related factors with subsequent local tumor control. METHODS AND MATERIALS: From 1977 to 1990, 196 subcutaneous/superficial lesions (179 measurable, 17 microscopic) in 151 patients with recurrent breast carcinoma of the chest wall were treated with superficial 915-MHz microwave hyperthermia and irradiation. The definition of min t43 > or = 10 min is that all monitored tumor catheters had a minimum of 1 hyperthermia session with temperatures > 43 degrees C for at least 10 min.
RESULTS: Factors correlating with local control on univariate analysis included length of survival (> or = 1 year vs. < 1 year) (p < 0.0001), specific absorption rate (SAR) (> or = 25% vs. < 25%) (p = 0.0001), minimum t43 > 10 min (p < 0.0001), tumor volume (p < 0.0001), tumor surface area (p < 0.0001), tumor depth (p = 0.0002), number of hyperthermia sessions (p = 0.0003), and current radiation dose (p = 0.0012). On multivariate analysis, the factors best correlated with ultimate local control were SAR (p < 0.001) and number of hyperthermia sessions (p = 0.003).
CONCLUSIONS: Multivariate analysis supports the importance of adequate specific absorption rate (SAR) coverage as a better predictor of local control than tumor volume, surface area, or depth. The explanation is that SAR can be correlated with the tumor surface area and depth, depending on the hyperthermia applicator characteristics. It is recommended that future clinical trials stratify study lesions into either SAR > or = 25% or < 25% because this can be readily estimated prior to initiating treatment. It is also recommended that future clinical trials attempt to have adequate lengths of follow-up after therapy to assess the results in long-term survivors.

Entities:  

Mesh:

Year:  1998        PMID: 9457823     DOI: 10.1016/s0360-3016(97)00740-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

Review 1.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

2.  Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning.

Authors:  Marianne Linthorst; Tomas Drizdal; Hans Joosten; Gerard C van Rhoon; Jacoba van der Zee
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

Review 3.  Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.

Authors:  Timothy M Zagar; James R Oleson; Zeljko Vujaskovic; Mark W Dewhirst; Oana I Craciunescu; Kimberly L Blackwell; Leonard R Prosnitz; Ellen L Jones
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 4.  Present and future technology for simultaneous superficial thermoradiotherapy of breast cancer.

Authors:  Eduardo G Moros; Jose Peñagaricano; Petr Novàk; William L Straube; Robert J Myerson
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  Evaluation of CEM43 degrees CT90 thermal dose in superficial hyperthermia: a retrospective analysis.

Authors:  Maarten de Bruijne; Bronno van der Holt; Gerard C van Rhoon; Jacoba van der Zee
Journal:  Strahlenther Onkol       Date:  2010-07-29       Impact factor: 3.621

6.  Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data.

Authors:  Vassilis Kouloulias; Sotiria Triantopoulou; Nikolaos Uzunoglou; Kyriaki Pistevou-Gompaki; Alfred Barich; Anna Zygogianni; George Kyrgias; Dimitris Kardamakis; Dimitris Pectasidis; John Kouvaris
Journal:  Breast Care (Basel)       Date:  2015-04       Impact factor: 2.860

7.  The Kadota Fund International Forum 2004--clinical group consensus.

Authors:  J van der Zee; Z Vujaskovic; M Kondo; T Sugahara
Journal:  Int J Hyperthermia       Date:  2008-03       Impact factor: 3.914

Review 8.  Simulation techniques in hyperthermia treatment planning.

Authors:  Margarethus M Paulides; Paul R Stauffer; Esra Neufeld; Paolo F Maccarini; Adamos Kyriakou; Richard A M Canters; Chris J Diederich; Jurriaan F Bakker; Gerard C Van Rhoon
Journal:  Int J Hyperthermia       Date:  2013-05-14       Impact factor: 3.914

9.  The utility of hyperthermia for local recurrence of breast cancer.

Authors:  Daigo Yamamoto; Toshio Inui; Yu Tsubota; Noriko Sueoka; Chizuko Yamamoto; Kayoko Kuwana; Mitsuo Yamamoto
Journal:  World J Surg Oncol       Date:  2012-09-27       Impact factor: 2.754

10.  Biological cell survival mapping for radiofrequency intracavitary hyperthermia combined with simultaneous high dose-rate intracavitary irradiation.

Authors:  H Kurosaki; H Sakurai; N Mitsuhashi; Y Tamaki; T Akimoto; T Takahashi; M Furuta; J I Saitoh; K Hayakawa; H Niibe
Journal:  Jpn J Cancer Res       Date:  2001-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.